期刊名称：JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
An official publication of the American Academy of Allergy, Asthma, and Immunology, the Journal of Allergy and Clinical Immunology brings timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other physicians concerned with clinical manifestations of allergies in their practice. Articles cover such topics as allergic and immunologic diseases, the latest therapies and treatment programs, occupational/industrial allergy, and studies of antigens, allergens, and the environment. The Journal of Allergy and Clinical Immunology is recommended for initial purchase in the Brandon-Hill study, Selected List of Books and Journals for the Small Medical Library. |
 |
Instructions to Authors
Editorial Office. Items pertaining to manuscripts submitted for publication, letters, and all other communications relating to the editorial management of the Journal should be sent to:
Donald Y. M. Leung, MD, PhD, Editor in Chief
The Journal of Allergy and Clinical Immunology
National Jewish Medical and Research Center
1400 Jackson St., Suite J324
Denver, CO 80206
Telephone: (303) 398-1963
Fax: (303) 270-2269
In January 2002, the Journal adopted a Web-based editorial office system with full electronic submission, review, and status update capabilities. All manuscripts must now be submitted online at the JACI抯 Editorial Manager (EM) Web site: http://JACI.editorialmanager.com. Electronic files of the manuscript contents must be uploaded at the Web site, and a PDF will be automatically built by the system. Required copies of the Submission Form, copyright documents, and permissions (when applicable) should be transmitted by fax to (303) 270-2269. The Required Submission Form and Transfer of Copyright statement can be downloaded from the EM home page. Glossy prints of illustrations should be clearly and completely labeled (see section A9, Figures) and sent directly to the Editorial Office by express mail or rapid courier.
Please refer to the information presented in the 揂TTENTION AUTHORS?section of the JACI抯 Editorial Manager (EM) Web site athttp://JACI.editorialmanager.com: Tutorial for Authors, Guidelines for Submitting a Revised Manuscript, Transfer of Copyright, Submission Checklist and General System Requirements are all available at the EM Web site. If problems are encountered in submitting a manuscript, or in the unusual event that electronic submission is not possible, please contact the Editorial Office at jacistaff@njc.org. Please provide the corresponding author抯 name, title of the manuscript, and a clear description of the problem.
Copyright. Most of the provisions of the Copyright Act of 1976 became effective on January 1, 1978. Therefore, EVERY MANUSCRIPT MUST BE ACCOMPANIED AT SUBMISSION BY THE FOLLOWING WRITTEN STATEMENT, SIGNED BY ALL AUTHORS:
?I>The undersigned author(s) transfer all copyright ownership of the manuscript [title of article] to Mosby, Inc, in the event the work is published. The undersigned warrant(s) that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been previously published. The author(s) confirm that they have reviewed and approved the final version of the manuscript.?BR>
Items are accepted for publication on the understanding that they are contributed solely to The Journal of Allergy and Clinical Immunology and have not been or will not be published elsewhere except in abstract form.
Authors will be consulted, when possible, regarding republication of their material.
Requesting Permission to Reuse Previously Published Material. Authors of manuscripts submitted to JACI must provide the Editorial Office with proof of permission to reuse previously published material for any figure or table that has appeared in another publication. To request permission, please contact the appropriate journal or publisher and provide the following information:
- Your name, institutional affiliation, mailing address, telephone and fax numbers, and e-mail address
- Source of previously published material: full title of journal or book, article title, authors, volume, year, and page numbers
- Amount of the material to be used: Please specify particular pages, tables or figures (specify table/figure numbers)
- Intended use of the published material: State that you are seeking publication in The Journal of Allergy and Clinical Immunology, and provide the article title, first author, JACI year and volume (or state in-press), and the number of the table or figure in the JACI submission where the material will appear.
- Upon obtaining permission to reuse the specified material, forward all documentation to the Editorial Office. Acceptance of a manuscript is conditional upon receipt of permission.
Liability. Statements and opinions expressed in the articles and communications herein are those of the author(s) and not necessarily those of the Editor(s) or publisher, and the Editor(s) and publisher disclaim any responsibility or liability for such material. Neither the Editor(s) nor the publisher guarantee, warrant, or endorse any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
Conflict of interest. The Journal requires all authors to acknowledge, on the title page of the manuscript, all funding sources that supported their work as well as all institutional or corporate affiliations of the authors. Authors are also required to disclose to the Editor, in a cover letter provided at the time of submission of a manuscript, any commercial associations that might pose a conflict of interest. These include consultant arrangements, stock or other equity ownership, patent licensing arrangements, or payments for conducting or publicizing the study. The disclosure will be held in strict confidence during the review process and will not influence any editorial decisions. However, if the paper is accepted for publication, the Editor will determine how any conflict of interest should be disclosed.
Manuscript length. Authors must comply with the page limits that have been established for each type of article. Manuscripts that exceed standard limits for length will be returned to the authors to be shortened before peer review can be initiated. Articles of excessive length will not be accepted for publication. As of July 1, 2001, the option to pay extra page charges for articles that exceed standard page limits will no longer be offered.
The Journal will consider publication of several types of manuscripts:
A. Original manuscripts
These should describe fully, but as concisely as feasible, the results of original clinical and/or laboratory research. For complete instructions regarding the online submission process, please refer to the Tutorial for Authors on the home page at http://JACI.editorialmanager.com. Be sure the entire manuscript (all text, legends, captions, etc.) is in a standard font such as Times New Roman, Arial, or Courier, size 12 font. All sections, including references, should be double-spaced, with margins of at least one inch on all sides. On each page, the last name of the first author and the page number should appear in the upper right corner. Begin numbering with the title page aspage 1.
Original articles may not exceed seven printed pages, including text, references, tables and figures. To estimate the number of printed pages that a manuscript will require, calculate one printed page for every three pages or 750 words of double-spaced, 12-point Courier typescript; one half page for every 25 references; and one third page for each 3??6?table or figure (or part of a multipart figure) plus legend. A printed page measures 6?wide by 9?long. Graphic presentations should be sized to one (3? or two (6? column widths. Authors must comply with the page limits established.
The manuscript should be organized in the order set forth below. Failure to follow this format may result in the manuscript being returned to the author(s) for revision before review.
- Title page. The full title should be concise. It should be followed by the list of authors, including their full names, highest academic degrees, and affiliations. Restrict the number of authors to those who have made material contributions to the research and who contributed to the writing and review of the manuscript. In the bottom half of the title page, list the corresponding author抯 name, address, telephone number, fax number, e-mail address and an address for reprint requests.
A total word count must be provided on the manuscript抯 title page. This total word count pertains to the body of the manuscript (Introduction through Discussion); the abstract should not be included in the count. Figure and table legends are included in the estimation of the overall space required for tables and figures.
- Abstract. Submit this component as a separate electronic file, which contains the title page and abstract, as an .rtf (rich text format) file. The abstract must be no longer than 250 words. It should summarize the results and conclusions concisely. Tabular data and acronyms/abbreviations should not be included. Abstracts should be structured as follows:
- Background: What is the major problem that prompted the study?
- Objective: What is the purpose of the study?
- Methods: How was the study done?
- Results: What are the most important findings?
- Conclusion: What is the most important conclusion drawn and what is the clinical relevance of the results?
- Keywords. A list of up to ten key words should follow the abstract.
- Abbreviations. Provide a list of any abbreviations/ acronyms (and their definitions) on a separate page following the keywords. Only standard abbreviations are to be used. Consult Scientific Style and Format by the Council of Biology Editors or the AMA抯 Manual of Style. (Abbreviations in the title are not acceptable. They should be avoided in the abstract, if possible.) A laboratory or chemical term or the name of a disease process that will be abbreviated must be spelled out at first mention, the acronym or abbreviation following in parentheses.
- Text. The manuscript should be written clearly and concisely in English. Authors whose primary language is not English should obtain assistance with writing to avoid grammatical problems. The text should be organized in sections as follows:Introduction, Methods, Results, and Discussion. Each section should begin on a new page. The generic terms for all drugs and chemicals should be used.
Study subject coordination. In studies involving human subjects, a statement describing approval by the Institutional Review Board is required. Studies involving experimental animals must include a statement in the Methods section indicating which guidelines for the care and use of the animals were followed (eg, the 揚rinciples of Laboratory Animal Care?formulated by the National Society for Medical Research or the 揋uide for the Care and Use of Laboratory Animals?prepared by the Institute of Laboratory Animal Resources, National Research Council, and published by the National Academy Press [revised 1996]).
- Acknowledgments. General acknowledgments for consultations, statistical analyses, and the like should be listed at the end of the text, including full names of individuals involved.
- References. References should follow Cumulated Index Medicus style. Manuscripts in preparation, personal communications, and other unpublished information should not be cited in the reference list but may be mentioned in the text in parentheses. The references must be identified in the text by superscript Arabic numerals and numbered in consecutive order as they are mentioned in the text. The list of references, in numeric sequence, should be typed double-spaced at the end of the article. The format should conform to that set forth in 揢niform Requirements for Manuscripts Submitted to Biomedical Journals?(Ann Intern Med 1997;126:36-47). Please note that inclusive page numbers are required. List all author抯 names when there are six or fewer; when there are seven or more, list the first six and add et al.
EXAMPLES OF REFERENCES:
- Journal article:
- Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, et al. Childhood leukaemia in Europe after Chernyobyl: 5-year follow-up. Br J Cancer 1996;73:1006-12.
- Book:
- Ringsven MD, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
- Chapter in a book:
- Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysi- ology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995.p. 465-78.
- Tables. If Tables appear in the manuscript, they must be included in the electronic submission. Tables should supplement, not duplicate, the text; they should be on separate pages, one table per page, and should be self-explanatory and numbered with Roman numerals in order of mention. Provide a brief title for each table. Define any abbreviations that appear at the bottom of the table. Glossy prints and reduced versions of typewritten tables are unacceptable. The table number should appear in the electronic file.
- Figures. If illustrations appear in the manuscript they must be submitted in electronic format as part of the manuscript. Complete instructions for online submission are available on the EM Web site, http://JACI.editorialmanager.com, on the home page under 揂TTENTION AUTHORS.?BR>Graphics software such as Photoshop or Illustrator is required (the publisher will not accept images created in presentation software such as Powerpoint, CorelDraw, or Harvard Graphics). Images must be provided in .tif or .eps electronic format.
A reasonable number of black and white figures will be published. Authors should consider submitting at least one color key figure or conceptual illustration that captures the essential message of the manuscript. This will enhance the article and provide clarity for the readers. Color illustrations will be reviewed and approved by the Editor.
Color images need to be in CMYK mode, with a resolution of at least 300 DPI (dots per inch). The figure number should appear beneath the figure so that it can be identified when viewed in the electronic format.
For any color image, duplicate glossy prints must be sent by mail to the Editorial Office at the time that electronic files are submitted. Original prints should not be mounted on paper. Hard copies of figures must be numbered lightly on the back with the figure number, the first author抯 last name, and an arrow marking the top edge. (Color laser prints or color photocopies are not acceptable.) Note: Glossy prints will be used at press for color reproduction.
Important: In colorizing your figure(s), we ask that you keep in mind that some of our readers are color-blind and are often unable to distinguish different colors in graphically represented data. To accommodate this group, we suggest that you consider some type of aid, such as labeling each column of a bar graph with an identifier or providing a key with symbols identifying each set of data being presented or compared. It is also helpful to use colors of varying intensity so that they are distinguishable as different shades of gray when viewed by the color-blind. We thank you for complying with this request.
Gray-scale images should be at least 300 DPI and include a proof. Combinations of gray-scale and line art should be at least 1200 DPI, accompanied by a proof. Line art (black and white, or color) should be at least 1200 DPI and include a proof.
Black and white graphs must be legible, printed in jet-black on white background. Each graph should be designed to be printed in a single 3-inch column.
High-resolution images (1200 DPI or better) are required. Value labels and legends should be in easily legible type font such as Times Roman or Helvetica Regular. Bold or italic typefaces are not acceptable except for special emphasis on particular words or phrases. For each label, the first letter should be in upper case and the remainder in lower case, not all capitals. Labels directly on the graph rather than in the legend are encouraged. Type size must be 14 point or more and line width 1 point or more for 6-inch graphics and proportionally larger for larger graphics. The fill for bar graphs or pie charts should be distinctive: avoid shading. If more than two bars are used in a graph, please use cross-hatching for adequate contrast. Fills with unnecessary patterns will be returned for revision. Three-dimensional graphics may be used only when there are three coordinates (x, y, and z).
Figures must be cited in the text and numbered in order of mention.
Figure legends should be typewritten, double-spaced, and listed on a separate sheet of paper before the tables. The legends should be succinct, serving the purpose of simple identification of the data or subject being presented and not as an explanation.
- Permissions. Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner and original author, along with complete information as to the source. Photographs of identifiable persons must be accompanied by signed releases showing informed consent. Because articles appear in both the print and online versions of the journal, wording in the permission should specify 損ermission to publish in all forms and media.?Failure to obtain electronic permission rights might result in the images not appearing in the online version.
- Nucleotide Sequence Data. When manuscripts include or describe original sequence data, authors must submit these data to GenBank. A footnote must include the accession number under which the data were submitted. Instructions are available from GenBank, Mail Stop K710, Los Alamos National Laboratory, Los Alamos, NM 87545; phone (505) 665-2177.
- Protein Sequence Data. When manuscripts include or describe original protein sequence data, authors must submit these data to Protein Identification Resource (PIR). A footnote must include the accession number under which the data were submitted. Instructions are available from PIR, National Biomedical Research Foundation, Georgetown University Medical Center, 3900 Reservoir Rd., N.W., Washington, DC 20007; phone (202) 687-1672.
- New Allergen Data. When manuscripts include or describe a hitherto unnamed allergen, authors must contact the WHO/IUIS Allergen Nomenclature Sub-Committee for approval of a new name. A footnote should indicate that the data have been submitted. A questionnaire is available from Allergen Nomenclature Sub-Committee, B鴊e All?10-12, DK-2970 H鴕sholm, Denmark; telephone 45-45-76-7777 #5116; fax 45-45-76-5152; Internet: anonymous FTP to biobase.dk:pub/who-iuis/newallergen.nomenclature and pub/who-iuis/newallergen.form.
B. Rapid publications
The Editors will consider succinct manuscripts (not more than 2000 words and two tables or figures) summarizing novel experimental results of exceptional importance or urgency. Authors should identify and justify such manuscripts in a cover letter to the Editors. The format and characteristics for these papers will be identical to those outlined for standard submission manuscripts. Such papers, if accepted, will appear at least one issue sooner than standard manuscripts. The Editors may choose (after notification to authors) to consider such manuscripts as regular publications.
C. Letters to the Editor
Letters to the Editor are brief reports of clinical or laboratory observations, substantiated by controlled data but limited in scope, and without sufficient depth of investigation to qualify as original articles. These manuscripts are reviewed in the Editorial Office and undergo peer review. Citation research shows that Letters to the Editor are indexed in Medline, accessible to literature searches, and cited as original articles.
A Letter to the Editor must:
- Be limited to two double-spaced printed pages, including illustrations (2 printed pages = 1500 words of text)
- Have a short, relevant title.
- Include a title page and unstructured abstract as a separate electronic file in .rtf format (see section A1). Although the abstract is not published with the Letter, it is necessary for preview by peers invited by the Editorial Office to review the manuscript).
- Begin with the salutation 揟o the Editor.?
- Close with the author抯 name(s), academic degree(s), institutions(s), and location(s).
- Have no more than ten references.
- List the references as complete bibliographic citations following the closure of the letter.
- Present lists of Key Words and Abbreviations, as relevant.
- Have no more than two single-part figures or tables.
- Be accompanied by a signed Transfer of Copyright statement signed by all authors.
D. Correspondence
Correspondence concerning recent publications in the Journal or other subjects of unique interest to the readership will be considered for publication and accepted based on their pertinence, their scientific quality, and available space in the Journal. When a particular Journal article is referenced in a correspondence considered acceptable for publication, response from the authors of the article will be requested. The Correspondence and Reply will both be published.
Correspondence must:
- Contain no more than 500 words (this count will include any brief tabular data).
- Have a complete title page (see section A1).
- Have a short, relevant title.
- List the references as complete bibliographic citations at the end of the letter with the journal article being discussed as the first reference.
- Cite references (where appropriate to the subject) but no more than three.
- Have no more than one table or figure.
- Begin with the salutation 揟o the Editor? close with the author抯 name(s), academic degree(s), institutions(s), and location(s).
- Be accompanied by a signed Transfer of Copyright statement. Copyright transfer will also be required of the respondents.
E. Review articles
Review articles published in the Journal are requested in collaboration with the programs of the Post-graduate Education and Continuing Medical Education Committees of the American Academy of Allergy, Asthma and Immunology. Current space constraints do not allow acceptance of unsolicited review manuscripts.
F. Rostrum articles
Opinion articles about subjects of particular interest and/or debate are accepted for peer review after preliminary review by the Editor. These articles are limited to six printed pages and should follow the guidelines for original articles, including the presence of an unstructured abstract of no more than 250 words.
Revision of manuscripts
Submission of revisions must be made electronically at the Journal抯 Web-based editorial office, Editorial Manager (EM), at http://jaci.editorialmanager.com. Please refer to the Guidelines for Submitting a Revision information available in the 揂TTENTION AUTHORS?section of the home page. Adherence to these guidelines is important to prevent a delay in processing the manuscript.
Important: When submitting a revision via EM, the author must change the Article Type in EM抯 Edit Submission screen. For each manuscript type there is a corresponding revision format. In the pull-down menu, select the appropriate revision article type, eg, if you submitted an Original article type, click on Revision桹riginal. This will give you access to items on the Attach Files screen that you will need to complete the revision submission. Ensure that the revised manuscript is prepared in accordance with the Journal抯 format and style for the type of article you are revising.
Include the following:
- Electronic files of the complete revised manuscript that include a marked version and an unmarked version. The marked revision should use strike-throughs to indicate deletions and underlining to indicate additions. Include the tables and figures with both versions.
- A point-by-point response to the comments made by reviewers, Editors, and the Editorial Office. In this response, state each ENTIRE AND EXACT COMMENT followed by your reply. Indicate the difference between the two by a change of font, style, or the words 揅omment?and 揜esponse.?If changes and/or additions have been made to the previous version of the manuscript, indication must be given of where these changes have been made in the manuscript or explanation of why the authors feel that the changes are not appropriate.
- Electronic files for each figure and table. (If changes have been made to the Figures during revision, or if the glossy prints have not been provided at an earlier time, then duplicate glossy prints must be sent to the Editorial Office by courier or express mail.)
Guidelines for submission of electronic manuscript files
Prepare the electronic files before you go online. Please note the formats for files that Editorial Manager can upload and the publisher can use.
- For text and table files: use Word, WordPerfect, RTF, and Text. Word and WordPerfect are preferred.
- For graphics files use .tif or Adobe Photoshop .eps format.
- Do not submit PowerPoint or Excel electronic formats. They cannot be used by the publisher.
- Do not submit files in HTML or PDF format. They cannot be used by the Publisher.
Please be sure that all text, legends, captions, etc., are in a standard font such as Times New Roman, Arial, or Courier. Use of Asian fonts can cause a file to fail to display in the PDF if the recipient computer does not have the correct language support program.
Tables, figures, and figure legends may be combined with the manuscript (MS) text and references. However, if they cause the file to fail to upload, break them into individual files and upload each separately.
Keyboarding the electronic manuscript
- All design considerations regarding typefaces, page layout and artwork will be handled by the publisher (Mosby) after an accepted paper has been transferred from the Editorial Office to the publisher. Please do not input any special typesetting codes.
- Be careful to distinguish between the letter O and the numeral 0 and between the letter I and the numeral 1.
- A 揾ard return?results from pressing the Enter key on the computer keyboard. Use hard returns only at the ends of paragraphs, titles, and headings, to separate items in a list, and so forth. Rely on the word processing program抯 word wrap (搒oft return? feature for all other endings.
- Use the word processing program抯 capabilities for bold, underlining, italic, subscript, and superscript. Text that is to be italicized in published form (genus + species designations) may be keyboarded through use of either italic or underlined text.
- Be sure to double-space between sentences.
- Do not use the word processing program抯 hyphenation capabilities.
- Do not right-justify or center any text or headings.
- Use two hyphens for a long dash.
- When creating a table, use the word processing program抯 table formatting feature; otherwise, use only tabs (not spaces) to align columns.
- In order to enable the publisher to use electronic files, it is crucial that the word processing program抯 footnote feature or endnote feature not be used to create reference citations. Type references in a numbered list at the end of the text, and use superscript numerals within the text to cite references. Reprints
Color overprints are offered to authors before publication of the Journal at the same price as black and white reprints. An overprint consists of stapled pages that are printed at the same time that the issue is printed, and the first and/or last page might contain part of the preceding article or the following article. Custom color reprints purchased after publication are extremely expensive, and therefore authors are encouraged to verify the costs of reprints versus overprints before publication of their article.
Updated May 23, 2003.
Please refer to the online Instructions for Authors at http://www.mosby.com/jaci for the most recent Journal specifications.
Editorial Board
Editor in Chief DONALD Y. M. LEUNG, MD, PhD Denver, Colo
Deputy Editors HAROLD S. NELSON, MD, AND STANLEY J. SZEFLER, MD Denver, ColoAND WILLIAM W. BUSSE, MD Madison, Wis
Associate Editors ANDREA J. APTER, MD, MSc Philadelphia, Pa BRUCE BOCHNER, MD Baltimore, Md ANTHONY J. FREW, MD, FRCP Southampton, United Kingdom QUTAYBA HAMID, MD, PhD Montreal, Quebec, CanadaAND WILLIAM T. SHEARER, MD, PhD Houston, Tex
Editorial Board
DAVID M. ESSAYAN, MD Baltimore, Md 2004
RICHARD F. LOCKEY, MD Tampa, Fla 2004
MARC E. ROTHENBERG, MD Cincinnati, Ohio 2004
SALLY E. WENZEL, MD Denver, Colo 2004
ROBERT S. ZEIGER, MD, PhD San Diego, Calif 2004
RAFEUL ALAM, MD, PhD Galveston, Tex 2005
JAMES R. BAKER, MD Ann Arbor, Mich 2005
I. LEONARD BERNSTEIN, MD Cincinnati, Ohio 2005
CHRIS J. CORRIGAN, MD, PhD London, United Kingdom 2005
REBECCA GRUCHALLA, MD, PhD Dallas, Tex 2005
LARRY BORISH, MD Charlottesville, Va 2006
REDWAN MOQBEL, PhD, FRCPath Edmonton, Alberta, Canada 2006
SANTA JEREMY ONO, PhD London, United Kingdom 2006
SCOTT SICHERER, MD New York, NY 2006
DALE UMETSU, MD, PhD Stanford, Calif 2006
ZUHAIR K. BALLAS, MD, PhD Iowa City, Iowa 2007
THOMAS BIEBER, MD, PhD Bonn, Germany 2007
PEYTON A. EGGLESTON, MD Baltimore, Md 2007
FRED FINKELMAN, MD Cincinnati, Ohio 2007
DAVID P. HUSTON, MD Houston, Tex 2007
PEDRO AVILA, MD San Francisco, Calif 2008
DENNIS LEDFORD, MD Tampa, Fla 2008
DAVID B. PEDEN, MD Chapel Hill, NC 2008
HARALD RENZ, MD Marburg, Germany 2008
HUGH A. SAMPSON, MD New York, NY 2008
DONATA VERCELLI, MD Tucson, Ariz 2008
ERIKA VON MUTIUS, MD, MSc Munich, Germany 2008
Board of Directors of the American Academy of Allergy, Asthma and Immunology
President LANNY J. ROSENWASSER, MD, FAAAAI
Denver, Colo
President-Elect MICHAEL SCHATZ, MD, FAAAAI
San Diego, Calif
Vice President F. ESTELLE R. SIMONS, MD, FAAAAI
Winnipeg, Manitoba, Canada
THOMAS B. CASALE, MD Omaha, Neb
THOMAS A. FLEISHER, MD, FAAAAI Bethesda, Md
STANLEY GOLDSTEIN, MD, FAAAAI Rockville Centre, NY
PAUL A. GREENBERGER, MD Chicago, Ill
RICHARD W. HONSINGER, Jr, MD Los Alamos, NM
Secretary/Treasurer THOMAS A. E. PLATTS-MILLS, MD, PhD, FAAAAI
Charlottesville, Va
Immediate Past President DEAN D. METCALFE, MD, FAAAAI
DHHS/NIH
Past-Past President GAIL G. SHAPIRO, MD, FAAAAI
Seattle, Wash
ROBERT F. LEMANSKE, Jr, MD Madison, Wis
ARNOLD I. LEVINSON, MD, FAAAAI Philadelphia, Pa
LOUIS M. MENDELSON, MD West Hartford, Conn
DENNIS R. OWNBY, MD Augusta, Ga
Executive Vice President KAY WHALEN, CAE
Address of Executive Office
AMERICAN ACADEMY OF ALLERGY, ASTHMA AND IMMUNOLOGY
611 East Wells Street
Milwaukee, WI 53202
(414) 272-6071
fax: (414) 272-6070
e-mail: jaci@aaaai.org
|
刊名字顺( Alphabetical List of Journals):
返回页首 